SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a…

Oruka Therapeutics, Inc. · CLUSTER filed Jun 15, 2026 at 18:52 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 15, 2026 at 18:52 ET

Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market transactions over a 5-day window. The sales represent only 0.06% of the company's $4.2B market cap, making them immaterial and likely routine portfolio diversification.

  • CEO Lawrence Klein sold 1,729 shares for ~$120K on June 15.
  • COO Laura Sandler sold 600 shares for ~$42K on June 15.
  • General Counsel Paul Quinlan sold 733 shares for ~$51K on June 15.
  • Director Carl Dambkowski sold 35,000 shares (two transactions) for ~$2.45M on June 11-12.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access